Elizabeth Trehu's Net Worth
$353 Thousand
Who is Elizabeth Trehu?
Elizabeth Trehu does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CONSTELLATION PHARMACEUTICALS INC, and Jounce Therapeutics, Inc..
SEC CIK
Elizabeth Trehu's CIK is 0001693456
Past Insider Trading and Trends
2021 was Elizabeth Trehu's most active year for acquiring shares with 7 total transactions. Elizabeth Trehu's most active month to acquire stocks was the month of January. 2021 was Elizabeth Trehu's most active year for disposing of shares, totalling 14 transactions. Elizabeth Trehu's most active month to dispose stocks was the month of February. 2018 saw Elizabeth Trehu paying a total of $136,539.30 for 145,207 shares, this is the most they've acquired in one year. In 2018 Elizabeth Trehu cashed out on 43,055 shares for a total of $311,619.42, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
CONSTELLATION PHARMACEUTICALS INC No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Jounce Therapeutics, Inc. No price found
Chief Medical OfficerElizabeth Trehu owns 103,417 units of Common Stock. In the year 2017 Elizabeth Trehu acquired a total of 162,615 shares in Jounce Therapeutics, Inc. at a cost of $216,939.30, Elizabeth also disposed a total of 59,198 shares of Jounce Therapeutics, Inc. equalling to $570,427.38.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -8.24% | -9.29K |
$1.11 | -$10,316.02 | 103.42K |
Jan 9 - Jan 10
| |||
Form 4
| +32.28% | 27.5K |
—
|
—
| 112.7K |
Feb 1
| |||
Form 4
| -8.96% | -8.38K |
$6.88 | -$57,700.20 | 85.2K |
Jan 7 - Jan 10
| |||
Form 4
|
—
|
0
|
$7.06 | -$81,936.00 | 93.58K |
Scheduled
|
Mar 29 - Mar 31
| ||
Form 4
| +31.19% | 22.25K |
—
|
—
| 93.58K |
Feb 1
| |||
Form 4
|
—
|
0
|
$8.02 | -$51,935.00 | 71.33K |
Scheduled
|
Jan 20
| ||
Form 4
| -6.91% | -5.30K |
$6.89 | -$36,497.52 | 71.33K |
Jan 7 - Jan 8
| |||
Form 4
| -2.77% | -2.18K |
$4.71 | -$10,276.44 | 76.63K |
Aug 14 - Aug 17
| |||
Form 4
| +39.34% | 22.25K |
—
|
—
| 78.81K |
Feb 3
| |||
Form 4
| -4.43% | -2.62K |
$7.78 | -$20,414.72 | 56.56K |
Jan 7
| |||
Form 4
| -3.80% | -2.34K |
$3.99 | -$9,329.56 | 59.19K |
Aug 14 - Aug 16
| |||
Form 4
| +56.65% | 22.25K |
—
|
—
| 61.52K |
Feb 1
| |||
Form 4
| +57.89% | 14.4K |
—
|
—
| 39.27K |
Aug 13
| |||
Form 4
|
∞
| 24.88K |
$4.02 | $99,997.50 | 24.88K |
Jun 8
| |||
Form 4
|
—
|
0
|
$14.54 | -$95,626.80 |
0
|
Scheduled
|
Mar 8
| ||
Form 4
|
—
|
0
|
$12.76 | -$79,453.32 |
0
|
Scheduled
|
Mar 5
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||